IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

IMCAS World Congress 2023
Program

FOCUS ON S160

FIDIA PHARMA Symposium - Discover a new generation of injectables with 200kDa HA and the pure science behind

Discover FIDIA FARMACEUTICI S P A's latest videos and news

Room: Room 351 - Level 3
Date: Friday 27 January 2023 at 14:00 to 15:30
Format: INDUSTRY SYMPOSIUM > promotional and educational session by the organizing company who presents their products and services directly to attendees

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
14:00	Prof Alain Ali MOJALLAL	Introduction		123005
14:05	Prof Alberto Giuseppe PASSI	Pure science behind 200kDa HA		123006
14:15	Dr Ezio COSTA	Capturing 200kDa HA’s biostimulating effect with auto-crosslinked technology \| My clinical experience		123007
14:27	Prof Andrea SBARBATI	New ultrasound skin imaging data on effects of 200kDa HA		123008
14:37	Prof Alain Ali MOJALLAL	A new generation, dual injectable: Combining 200 kDa (ACP technology) with crosslinked HA \| My clinical experience		123009
14:49	Dr Andreyna DE MOTA	Achieving natural look with Hyal-System DUO		123010
15:01	Dr Michele RICCIO	My experience combining ACP technology with Nanofat treatment		123011
15:13	Dr Jacopo GALLOTTI	My experience combining ACP technology with laser treatment		123012
15:25		Q & A		123013

Go to previous session

Go to next session

Prof Alain Ali MOJALLAL

Plastic Surgeon

France

Other author(s) :

Introduction

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Alberto Giuseppe PASSI

Italy

Other author(s) :

Pure science behind 200kDa HA

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Ezio COSTA

Italy

Other author(s) :

Capturing 200kDa HA’s biostimulating effect with auto-crosslinked technology | My clinical experience

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Andrea SBARBATI

Anatomist

Italy

Other author(s) :

New ultrasound skin imaging data on effects of 200kDa HA

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Alain Ali MOJALLAL

Plastic Surgeon

France

Other author(s) :

A new generation, dual injectable: Combining 200 kDa (ACP technology) with crosslinked HA | My clinical experience

Dr Andreyna DE MOTA

Dermatologist

Spain

Other author(s) :

Achieving natural look with Hyal-System DUO

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Michele RICCIO

Plastic Surgeon

Italy

Other author(s) :

My experience combining ACP technology with Nanofat treatment

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): Fidia

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Jacopo GALLOTTI

Plastic Surgeon

Italy

Other author(s) :

My experience combining ACP technology with laser treatment

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): FIDIA honoraria for the congress being

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Q & A

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS World Congress 2023 Program

FOCUS ON S160

FIDIA PHARMA Symposium - Discover a new generation of injectables with 200kDa HA and the pure science behind

Lectures of the session

IMCAS World Congress 2023
Program